NSE filing, NSE: ISHAN. Summary written from the filing by ALFA Finder's alert engine.
Ishan International Ltd: key numbers
- Share price
- ₹0.50
- Market cap
- ₹10.81 Cr
- Revenue (annual)
- ₹26.89 Cr
- Net profit (annual)
- ₹0.40 Cr
- P/E (TTM)
- 27.2×Sector 52.0×
- Promoter holding
- 48.32%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ishan International Ltd
All →Ishan International Annual General Meeting
Ishan International Limited held its 31st Annual General Meeting on September 18, 2026, via video conferencing to transact business as stated in the notice.
Ishan International Annual General Meeting
Ishan International Limited issued a notice for its Annual General Meeting scheduled on September 18, 2026. The agenda includes financial adoption and director remuneration approvals.
Ishan International Board Meeting Outcome
Ishan International Limited held a board meeting, approving director re-appointments, remuneration revisions, and the upcoming 31st Annual General Meeting. It also discussed regulatory compliance matters.
Ishan International Legal & Regulatory
Ishan International Limited received a SEBI Show Cause Notice regarding the utilization of its IPO proceeds. The company plans to apply for settlement proceedings.
Ishan International Board Meeting Outcome
Ishan International's Board approved the half‑year financial results and addressed the Exchange's observations. The clarification confirms the results are unchanged and the board meeting details are recorded.
Ishan International Board Meeting Outcome
Ishan International's board approved investing surplus funds into shares, debentures, and bonds. This strategic move aims to optimize treasury management and enhance non-operational income.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.